Central Serous Chorioretinopathy, Corticosteroids, and Uveitis

REFERENCES

• Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol. 2011;22:166–173.
   PubMed Web of Science ®Google Scholar
• Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86:126–145.
   PubMed Web of Science ®Google Scholar
• Marcuson J, Riley T. Central serous chorioretinopathy. Optometry. 2008;79:241–251.
   PubMedGoogle Scholar
• Haimovici R, Koh S, Gagnon DR, et al. Central Serous Chorioretinopathy Case-Control Study Group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004;111:244–249.
   PubMed Web of Science ®Google Scholar
• Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47:431–448.
   PubMed Web of Science ®Google Scholar
• Carvalho-Recchia CA, Yannuzzi LA, Negrão S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002;109:1834–1837.
   PubMed Web of Science ®Google Scholar
• Jampol LM, Weinreb R, Yannuzzi L. Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology. 2002;109:1765–1766.
   PubMedGoogle Scholar
• Karadimas P, Bouzas EA. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study. Graefes Arch Clin Exp Ophthalmol. 2004;242:800–802.
   PubMed Web of Science ®Google Scholar
• Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology. 2003;110:698–703.
   PubMed Web of Science ®Google Scholar
• Jampol LM, Weinreb R, Yannuzzi L. Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology. 2002;109:1765–1766.
   PubMedGoogle Scholar
• Arndt C, Sari A, Ferre M, et al. Electrophysiological effects of corticosteroids on the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2001;42:472–475.
   PubMed Web of Science ®Google Scholar
• Sibayan SA, Kobuch K, Spiegel D, et al. Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelial cells in vitro: possible implications on the pathogenesis of central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2000;238:515–519.
   PubMed Web of Science ®Google Scholar
• Yamada R, Yamada S, Ishii A, et al. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi. 1993;97:955–960.
   PubMedGoogle Scholar
• Caccavale A, Romanazzi F, Imparato M, et al. Central serous chorioretinopathy: a pathogenetic model. Clin Ophthalmol. 2011;5:239–243.
   PubMedGoogle Scholar
• Karadimas P, Kapetanios A, Bouzas EA. Central serous chorioretinopathy after local application of glucocorticoids for skin disorders. Arch Ophthalmol. 2004;122:784–786.
   PubMedGoogle Scholar
• Fernandez CF, Mendoza AJ, Arevalo JF. Central serous chorioretinopathy associated with topical dermal corticosteroids. Retina. 2004;24:471–474.
   PubMed Web of Science ®Google Scholar
• Mondal LK, Sarkar K, Datta H, et al. Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid. Indian J Ophthalmol. 2005;53:132–134.
   PubMedGoogle Scholar
• Iida T, Spaide RF, Negrao SG, et al. Central serous chorioretinopathy after epidural corticosteroid injection. Am J Ophthalmol. 2001;132:423–425.
   PubMed Web of Science ®Google Scholar
• Haimovici R, Gragoudas ES, Duker DS, et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology. 1997;104:1653–1660.
   PubMed Web of Science ®Google Scholar
• Fardin B, Weissgold DJ. Central serous chorioretinopathy after inhaled steroid use for post-mycoplasmal bronchospasm. Br J Ophthalmol. 2002;86:1065–1066.
   PubMed Web of Science ®Google Scholar
• Shah VA, Randhawa S, Boldt HC, et al. Central serous chorioretinopathy in giant cell arteritis. Semin Ophthalmol. 2006;21:45–48.
   PubMedGoogle Scholar
• Bevis T, Ratnakaram R, Smith MF, et al. Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis. Clin Exp Ophthalmol. 2005;33:437–439.
   PubMedGoogle Scholar
• Bouyon A, Costedoat-Chalumeau N, Limal N, et al. Central serous chorioretinopathy and systemic diseases report of 2 cases associated with corticotherapy. Rev Med Interne. 2006;27:487–491.
   PubMedGoogle Scholar
• Edalati K, Roesch MT, Buchanan ML, et al. Central serous chorioretinopathy and idiopathic nonhistaminergic angioedema. Can J Ophthalmol. 2009;44:606–607.
   PubMedGoogle Scholar
• Otsuka S, Ohba N, Nakao K. A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina. 2002;22:25–32.
   PubMed Web of Science ®Google Scholar
• Bowie EM, Folk JC, Barnes CH. Corticosteroids, central serous chorioretinopathy, and neurocysticercosis. Arch Ophthalmol. 2004;122:281–283.
   PubMedGoogle Scholar
• Kunavisarut P, Pathanapitoon K, Van Schooneveld M, et al. Chronic central serous chorioretinopathy associated with serous retinal detachment in a series of Asian patients. Ocul Immunol Inflamm. 2009;17:269–277.
   PubMed Web of Science ®Google Scholar
• Kang JE, Kim HJ, Boo HD, et al. Surgical management of bilateral exudative retinal detachment associated with central serous chorioretinopathy. Korean J Ophthalmol. 2006;20:131–138.
   PubMedGoogle Scholar
• Yang CM, Lin CP. Bullous retinal detachment in a patient with central serous chorioretinopathy. J Formos Med Assoc. 1998;97:711–714.
   PubMed Web of Science ®Google Scholar
• Fujimoto H, Gomi F, Wakabayashi T, et al. Morphologic changes in acute central serous chorioretinopathy evaluated by Fourier-domain optical coherence tomography. Ophthalmology. 2008;115:1494–1500,500.e1–2.
   Google Scholar
• Yamaguchi Y, Otani T, Kishi S. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2007;144:260–265.
   PubMed Web of Science ®Google Scholar
• Menchini U, Virgili G, Lanzetta P, et al. Indocyanine green angiography in central serous chorioretinopathy: ICG angiography in CSC. Int Ophthalmol. 1997;21:57–69.
   PubMed Web of Science ®Google Scholar
• Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol. 2007;27:173–182.
   PubMedGoogle Scholar
• Koizumi H, Maruyama K, Kinoshita S. Blue light and near-infrared fundus autofluorescence in acute Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2010;94:1499–1505.
   PubMed Web of Science ®Google Scholar
• Dinc UA, Tatlipinar S, Yenerel M, et al. Fundus autofluorescence in acute and chronic central serous chorioretinopathy. Clin Exp Optom. 2011;94:452–457.
   PubMed Web of Science ®Google Scholar
• Roisman L, Lavinsky D, Magalhaes F, et al. Fundus autofluorescence and spectral domain OCT in central serous chorioretinopathy. J Ophthalmol. 2011;2011:706–849.
   Google Scholar
• Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology. 1995;102:737–747.
   PubMed Web of Science ®Google Scholar
• Arantes TE, Garcia CR, Rossi MR, et al. Spectral domain optical coherence tomography and angiographic findings in central serous chorioretinopathy complicated by bilateral nonrhegmatogenous retinal detachment associated with systemic corticosteroids. Ocul Immunol Inflamm. 2009;17:316–318.
   PubMed Web of Science ®Google Scholar
• Ishida Y, Kato T, Minamoto A, et al. Retinal pigment epithelial tear in a patient with central serous chorioretinopathy treated with corticosteroids. Retina. 2004;24:633–636.
   PubMed Web of Science ®Google Scholar
• Gómez-Valcárcel M, Sinisterra-Pava JP, Arellanes-García L. Central serous chorioretinopathy versus sympathetic ophthalmia: case report. Arch Soc Esp Oftalmol. 2004;79:507–510.
   PubMedGoogle Scholar
• Cunningham ET Jr, Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology. 1996;103:2081–2090.
   PubMed Web of Science ®Google Scholar
• Bouzas E, Mastorakos G. Central serous retinopathy in systemic lupus erythematosus: a manifestation of the disease or of its treatment? Br J Ophthalmol. 1994;78:420–421.
   PubMedGoogle Scholar
• Khng CG, Yap EY, Au-Eong KG, et al. Central serous retinopathy complicating systemic lupus erythematosus: a case series. Clin Exp Ophthalmol. 2000;28:309–313.
   PubMedGoogle Scholar
• Salchow DJ, Weiss MJ. Retinal pigment epithelial detachment in sarcoidosis. Ocul Immunol Inflamm. 2006;14:245–248.
   PubMed Web of Science ®Google Scholar
• Sheth HG, Laverde-Konig T, Raina J. TINU-associated retinal pigment epithelium detachments: a possible novel posterior segment feature. Int Ophthalmol. 2009;29:179–181.
   PubMedGoogle Scholar
• Hannouche D, Korobelnik JF, Cochereau I, et al. Systemic lupus erythematosus with choroidopathy and serous retinal detachment. Int Ophthalmol. 1995;19:125–127.
   PubMed Web of Science ®Google Scholar
• Laviña AM, Agarwal A, Hunyor A, et al. Lupus choroidopathy and choroidal effusions. Retina. 2002;22:643–647.
   PubMed Web of Science ®Google Scholar
• Gharbiya M, Bozzoni-Pantaleoni F, Augello F, et al. Indocyanine green angiographic findings in systemic lupus erythematosus choroidopathy. Am J Ophthalmol. 2002; 134:286–290.
   PubMed Web of Science ®Google Scholar
• Gharbiya M, Pecci G, Baglio V, et al. Indocyanine green angiographic findings for patients with systemic lupus erythematosus nephropathy. Retina. 2006;26:159–164.
   PubMed Web of Science ®Google Scholar
• Gupta SR, Suhler EB, Rosenbaum JT. The dilemma of central serous retinopathy, a corticosteroid-induced complication, in patients with ocular inflammatory disease. J Rheumatol. 2010;37:1973–1974.
   PubMedGoogle Scholar
• Schalenbourg A, Leys A, De Courten C, et al. Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders. Klin Monbl Augenheilkd. 2002;219:264–267.
   PubMed Web of Science ®Google Scholar
• Baumal CR, Martidis A, Truong SN. Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis. Arch Ophthalmol. 2004;122:926–928.
   PubMedGoogle Scholar
• Chaine G, Haouat M, Menard-Molcard C, et al. Central serous chorioretinopathy and systemic steroid therapy. J Fr Ophtalmol. 2001;24:139–146.
   PubMedGoogle Scholar
• Imasawa M, Ohshiro T, Gotoh T, et al. Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema. Acta Ophthalmol Scand. 2005;83:132–133.
   PubMedGoogle Scholar
• Bouzas EA, Moret P, Pournaras CJ. Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids. Graefes Arch Clin Exp Ophthalmol. 1999;237:166–168.
   PubMedGoogle Scholar
• Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol. 1997;41:180–185.
   PubMed Web of Science ®Google Scholar
• Fawzi AA, Holland GN, Kreiger AE, et al. Central serous chorioretinopathy after solid organ transplantation. Ophthalmology. 2006;113:805–813.e5.
   PubMed Web of Science ®Google Scholar
• Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology. 1995;102:737–747.
   PubMed Web of Science ®Google Scholar
• Hooymans JM. Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids. Graefes Arch Clin Exp Ophthalmol. 1998;236:876–879.
   PubMedGoogle Scholar
• Loo JL, Lee SY, Ang CL. Long-term corticosteroids lead to blindness? A case series of central serous chorioretinopathy induced by corticosteroids. Ann Acad Med Singapore. 2006;35:496–499.
   PubMed Web of Science ®Google Scholar
• Fawzi AA, Holland GN, Kreiger AE, et al. Central serous chorioretinopathy after solid organ transplantation. Ophthalmology. 2006;113:805–13.e5.
   PubMed Web of Science ®Google Scholar
• Schatz H, McDonald HR, Johnson RN, et al. Subretinal fibrosis in central serous chorioretinopathy. Ophthalmology. 1995;102:1077–1088.
   PubMedGoogle Scholar
• Sharma T, Badrinath SS, Gopal L, et al. Subretinal fibrosis and nonrhegmatogenous retinal detachment associated with multifocal central serous chorioretinopathy. Retina. 1998;18:23–29.
   PubMed Web of Science ®Google Scholar
• Sharma T, Shah N, Rao M, et al. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology. 2004;111:1708–1714.
   PubMed Web of Science ®Google Scholar
• Iida T, Spaide RF, Haas A, et al. Leopard-spot pattern of yellowish subretinal deposits in central serous chorioretinopathy. Arch Ophthalmol. 2002;120:37–42.
   PubMedGoogle Scholar
• Mendrinos E, Mavrakanas N, Dang-Burgener NP, et al. Bilateral multifocal retinal pigment epithelium detachments associated with systemic corticosteroids. Eur J Ophthalmol. 2008;18:649–651.
   PubMed Web of Science ®Google Scholar
• Harikrishnan A, Anderson K, Patra S. Severe visual loss secondary to central serous chorioretinopathy following prolonged immue suppression with oral prednisolone. JRSM Short Rep. 2010;1:31.
   PubMedGoogle Scholar
• Lim JW, Kim MU. The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249:969–974.
   PubMed Web of Science ®Google Scholar
• Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1984;68:329–331.
   PubMed Web of Science ®Google Scholar